Arbe Robotics Ltd. filings document foreign private issuer reports for a perception radar company whose ordinary shares trade under ARBE. Its Form 6-K disclosures cover quarterly and annual financial results, conference-call materials, consolidated financial statements incorporated by reference into registration statements, and business updates tied to radar technology for automotive and non-automotive applications.
The filing record also includes capital-structure and governance matters, including an underwritten registered direct offering of ordinary shares, series A convertible bond terms and bondholder voting materials, annual general meeting results, authorized share-capital amendments, director elections, executive leadership changes, and Nasdaq continued-listing compliance notices.
Arbe Robotics Ltd. (ARBEW) submitted a Form 144 disclosing a proposed sale of 162,158 ordinary shares with an aggregate market value of $315,170, scheduled approximately for 09/22/2025 on NASDAQ. The securities were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Ltd., totaling 4,261,734 shares at cash payment. The filing also reports recent sales by Canaan Partners Israel of 100,000 and 87,842 ordinary shares on 09/18/2025 and 09/19/2025 respectively, generating gross proceeds of $149,690.00 and $147,864.44. The filing includes the required representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for ARBEW shows an intended sale of 87,842 ordinary shares on or about 09/19/2025 through Raymond James & Associates on NASDAQ, with an aggregate market value of $147,574.56. The filing reports that these shares were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Inc for cash, and that the filer previously sold 100,000 ordinary shares on 09/18/2025 (gross proceeds $147,684.05) by Canaan Partners Israel. The issuer outstanding share count is listed as 105,163,188. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice: A holder intends to sell 100,000 ordinary shares of Arbe Robotics Ltd. (ticker ARBEW) through Raymond James & Associates on 09/18/2025 on the NASDAQ. The aggregate market value of the proposed sale is reported as $149,690.00 and the issuer has 105,163,188 shares outstanding. The shares were originally acquired on 03/30/2016 in a private placement from Arbe Robotics Ltd., with 4,261,734 shares listed as acquired on that date, and payment was in cash. No securities sold in the past three months are reported.
Arbe Robotics Ltd. reported the results of its 2025 annual general meeting. Shareholders elected Dr. Noam Arkind and Mr. Chris Van Dan Elzen as Class I directors, adding Van Dan Elzen to the company’s board.
Investors also approved an increase in Arbe’s registered share capital by NIS 7,560, representing 35,000,000 additional ordinary shares, bringing the total authorized ordinary shares to 200,000,000 and amending the Articles of Incorporation accordingly. All proposals described in the previously furnished proxy statement were approved by the required majorities.
The company noted that a press release announcing Van Dan Elzen’s election was issued on September 18, 2025 and furnished as an exhibit, and reiterated standard cautions about forward-looking statements, including risks related to marketing its chipset technology, global trade policies, and geopolitical and economic conditions affecting Israel.
Arbe Robotics Ltd. furnished a Form 6-K reporting that the company has posted its proxy statement and the form of proxy card for the 2025 Annual General Meeting on its website at https://arberobotics.com/. The filing identifies the exhibits as Exhibit 99.1 (Proxy Statement for the 2025 AGM) and Exhibit 99.2 (Form of Proxy Card for the 2025 AGM). The document lists Kobi Marenko as CEO.